Transmedics Group

Transmedics Group

World Rank (Aug-2026)
4978
Market Cap (Aug-2026)
3.072 Billion USD
Market Cap (Mar-08-2026)
4.446 Billion USD
World Rank (Jan-05-2024)
5,015
Market Cap (Jan-05-2024)
2.451 Billion USD
World Rank (Jul-30-2023)
4,380
Market Cap (Jul-30-2023)
2.972 Billion USD
World Rank (Jan-07-2022)
13,413
Market Cap (Jan-07-2022)
0.504 Billion USD
World Rank (Jan-01-2021)
10,783
Market Cap (Jan-01-2021)
0.541 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TMDX
Employee Count
212
Employee Count as of Date
As on Dec-2022
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
605 Million USD
Annual Operating Income in USD
109 Million USD
Annual Net Income in USD
190 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,068 Million USD
Total Liabilities in USD
595 Million USD
Total Equity in USD
473 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Healthcare Service
Medical Equipment / Instruments
Company Website
TRANSMEDICS GROUP
Yahoo
Yahoo @ Nasdaq
Company Profile

TransMedics Group is a Revolutionary Technology company for preserving organs used in the treatment of end stage heart, lung and liver failure. The headquarters is in USA.

Facts About Company

TransMedics Group company annual revenue was 93.4 million USD and annual net loss was -36 million USD for year ending Dec-2022.

TransMedics had 212 employees as on Dec-2022.

Founded Year
1998
IPO Year
2019
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

Share